Generation Bio Co. (GBIO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Geoff McDonough
Employees:
85
301 BINNEY STREET, CAMBRIDGE, MA 02142
857-529-5908

Generation Bio Co. operates as a biotechnology company. The Company engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases. Generation Bio serves customers in the United States.

Data derived from most recent annual or quarterly report
Market Cap 399.008 Million Shares Outstanding57.001 Million Avg 30-day Volume 463.659 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.01
Price to Revenue0.0 Debt to Equity0.0 EBITDA-114.04 Million
Price to Book Value1.0441 Operating Margin0.0 Enterprise Value23.426 Million
Current Ratio20.161 EPS Growth0.281 Quick Ratio19.946
1 Yr BETA 1.8822 52-week High/Low 28.67 / 3.96 Profit Margin0.0
Operating Cash Flow Growth-30.9073 Altman Z-Score1.6945 Free Cash Flow to Firm -84.286 Million
Earnings Report2022-08-04
View SEC Filings from GBIO instead.

View recent insider trading info

Funds Holding GBIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GBIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-21:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-02-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-10:
    Item 8.01: Other Events
  • 8-K: filed on 2021-12-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    JONAS JEFFREY M

    19,200 2022-06-09 1

    ROWLAND CHARLES A JR

    19,200 2022-06-09 1

    CHRISTENSEN GUSTAV

    19,200 2022-06-09 1

    QUINN ANTHONY G.

    19,200 2022-06-09 2

    RHODES JASON P

    19,200 2022-06-09 3

    COOPER RONALD HAROLD WILFRED

    19,200 2022-06-09 1

    STEHMAN-BREEN CATHERINE

    19,200 2022-06-09 1

    NICHOLSON DONALD WILLIAM

    19,200 2022-06-09 2

    PAONE ANTOINETTE CHIEF OPERATING OFFICER

    110,000 2022-02-10 2

    MCDONOUGH GEOFF PRESIDENT AND CEO

    562,500 2022-01-21 1

    KERR DOUGLAS CHIEF MEDICAL OFFICER

    178,500 2022-01-21 2

    STANTON MATTHEW CHIEF SCIENTIFIC OFFICER

    178,500 2022-01-21 6

    NORKUNAS MATTHEW CHIEF FINANCIAL OFFICER

    178,500 2022-01-21 1

    ZIMMERMANN TRACY CHIEF DEVELOPMENT OFFICER

    178,500 2022-01-21 1

    ATLAS VENTURE ASSOCIATES X, L.P.

    ATLAS VENTURE ASSOCIATES X, LLC

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • 10% Owner
    608 2021-09-27 2

    ATLAS VENTURE FUND X, L.P.

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    • 10% Owner
    8,278,876 2021-09-17 1

    ATLAS VENTURE ASSOCIATES X, L.P.

    ATLAS VENTURE ASSOCIATES X, LLC

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • 10% Owner
    31,616 2021-06-21 2

    ATLAS VENTURE ASSOCIATES X, L.P.

    ATLAS VENTURE ASSOCIATES X, LLC

    • 10% Owner
    9,111,939 2021-04-12 0

    ATLAS VENTURE FUND X, L.P.

    • 10% Owner
    9,111,939 2021-03-16 1

    ANGELINO MARK D. CHIEF OPERATING OFFICER

    No longer subject to file 2021-02-05 0

    ZONE HEALTHCARE HOLDINGS, LLC

    FARALLON CAPITAL MANAGEMENT LLC

    FARALLON PARTNERS L L C/CA

    DREYFUSS PHILIP D

    FISCH MICHAEL B.

    FRIED RICHARD B

    KIM DAVID T

    LINN MICHAEL G

    PATEL RAJIV A

    ROBERTS THOMAS G. JR.

    • MEMBER OF GROUP OWNING 10%MANAGER OF ZHH LLCFARALLON GENERAL PARTNERMANAGING MEMBERMANAGING MEMBERMANAGING MEMBERMANAGING MEMBERMANAGING MEMBERMANAGING MEMBERMANAGING MEMBER
    3,837,638 2020-06-16 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    No longer subject to file 2020-06-16 0

    INVUS PUBLIC EQUITIES, L.P.

    MINNE PASCAL

    ARTAL INTERNATIONAL S.C.A.

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    ARTAL TREASURY LTD

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    • 10% Owner
    No longer subject to file 2020-06-16 0

    SEYBOLD WILLIAM

    SPOKES ANDREW J M

    WARREN JOHN R.

    WEHRLY MARK C

    • MEMBER OF GROUP OWNING 10%MANAGING MEMBERMANAGING MEMBERMANAGING MEMBER
    3,837,638 2020-06-16 0

    CASDIN CAPITAL, LLC

    CASDIN ELI

    • 10% Owner
    No longer subject to file 2020-06-16 0

    ATLAS VENTURE FUND X, L.P.

    ATLAS VENTURE ASSOCIATES X, LLC

    ATLAS VENTURE ASSOCIATES X, L.P.

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • 10% Owner
    12,630,758 2020-06-16 1

    WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

    • 10% Owner
    No longer subject to file 2020-06-16 0

    DIPALMA STEPHEN J. SEE REMARKS

    • Officer
    0 2020-06-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    JONAS JEFFREY M

    2022-06-13 16:06:06 -0400 2022-06-09 A 19,200 a 19,200 direct

    RHODES JASON P

    2022-06-13 16:05:56 -0400 2022-06-09 A 19,200 a 19,200 direct

    COOPER RONALD HAROLD WILFRED

    2022-06-13 16:05:50 -0400 2022-06-09 A 19,200 a 19,200 direct

    CHRISTENSEN GUSTAV

    2022-06-13 16:05:47 -0400 2022-06-09 A 19,200 a 19,200 direct

    STEHMAN-BREEN CATHERINE

    2022-06-13 16:05:24 -0400 2022-06-09 A 19,200 a 19,200 direct

    ROWLAND CHARLES A JR

    2022-06-13 16:05:38 -0400 2022-06-09 A 19,200 a 19,200 direct

    NICHOLSON DONALD WILLIAM

    2022-06-13 16:05:34 -0400 2022-06-09 A 19,200 a 19,200 direct

    QUINN ANTHONY G.

    2022-06-13 16:05:14 -0400 2022-06-09 A 19,200 a 19,200 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GENERATION BIO CO GBIO 2022-06-24 22:15:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 21:45:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 21:15:04 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 20:45:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 20:15:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 19:45:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 19:15:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 18:45:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 18:15:04 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 17:45:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 17:15:03 UTC 1.1348 0.4352 550000
    GENERATION BIO CO GBIO 2022-06-24 16:45:03 UTC 1.1349 0.4351 550000
    GENERATION BIO CO GBIO 2022-06-24 16:15:03 UTC 1.1349 0.4351 550000
    GENERATION BIO CO GBIO 2022-06-24 15:45:03 UTC 1.1349 0.4351 550000
    GENERATION BIO CO GBIO 2022-06-24 15:15:03 UTC 1.1349 0.4351 550000
    GENERATION BIO CO GBIO 2022-06-24 14:45:03 UTC 1.1096 0.4604 550000
    GENERATION BIO CO GBIO 2022-06-24 14:15:03 UTC 1.1096 0.4604 550000
    GENERATION BIO CO GBIO 2022-06-24 13:45:03 UTC 1.1096 0.4604 550000
    GENERATION BIO CO GBIO 2022-06-24 13:15:03 UTC 1.1096 0.4604 550000
    GENERATION BIO CO GBIO 2022-06-24 12:45:03 UTC 1.1096 0.4604 550000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund GBIO -2100.0 shares, $-52647.0 2021-09-30 N-PORT
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio GBIO -26300.0 shares, $-659341.0 2021-09-30 N-PORT

    Elevate your investments